Skip to main navigation
Skip to search
Skip to main content
University of Arizona Home
Search content at University of Arizona
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease
Ramon Velazquez
, Darren M. Shaw
, Antonella Caccamo
, Salvatore Oddo
COM Phx Basic Medical Sci
Research output
:
Contribution to journal
›
Article
›
peer-review
33
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alzheimer's Disease
100%
PIM-1
100%
Novel Therapeutics
100%
Pim Kinase Inhibitor
87%
Proline-rich
62%
3xTg-AD
50%
Mammalian Target of Rapamycin (mTOR)
37%
Alzheimer's Disease Model
37%
Phosphorylation
25%
Hippocampus
25%
Cognitive Deficits
25%
Tau Pathology
25%
Proteasome Activity
25%
Plaque
12%
Drug Discovery
12%
Cognitive Function
12%
Protein Kinase
12%
Human Trials
12%
Non-transgenic
12%
Transgenic Mice
12%
Immunoreactivity
12%
Memory Function
12%
Spatial Memory
12%
Protein Synthesis
12%
Alzheimer's Disease Patient
12%
Blood-brain Barrier
12%
Neuropathology
12%
Protein Degradation
12%
Phosphorylated tau
12%
Spatial Reference Memory
12%
Neurofibrillary Tangles
12%
Neurodegenerative Diseases
12%
Protein Homeostasis
12%
Biochemistry, Genetics and Molecular Biology
Proline
100%
Mouse
80%
Mechanistic Target of Rapamycin
60%
Tau
60%
Proteasome
40%
Protein Biosynthesis
20%
Clinical Trial
20%
Transgenic Mouse
20%
Protein Kinases
20%
Protein Catabolism
20%
Blood Brain Barrier
20%
Working Memory
20%
Immunoreactivity
20%
Amyloid
20%
Neurofibrillary Tangle
20%
Cognition
20%
Protein Homeostasis
20%
Memory
20%
Reference Memory
20%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Proline
41%
Mouse
33%
Mammalian Target of Rapamycin
25%
Proteasome
16%
Cognitive Defect
16%
Malignant Neoplasm
8%
Disease
8%
Clinical Trial
8%
Drug Discovery
8%
Protein Kinases
8%
Blood-Brain Barrier
8%
Transgenic Mouse
8%
Amyloid
8%
Neurofibrillary Tangle
8%
Neuroscience
Alzheimer's Disease
100%
Proline
41%
Mammalian Target of Rapamycin
25%
Hippocampus
16%
Cognitive Disorders
16%
Proteasome
16%
Protein Kinases
8%
Protein Biosynthesis
8%
Working Memory
8%
Blood Brain Barrier
8%
Cognitive Function
8%
Amyloid
8%
Reference Memory
8%
Neurodegenerative Disorder
8%